Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics, Inc., 13506 [2017-04875]
Download as PDF
<![CDATA[
13506
Federal Register / Vol. 82, No. 47 / Monday, March 13, 2017 / Notices
Issued: March 7, 2017.
Lisa R. Barton,
Secretary to the Commission.
Dated: March 6, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–04790 Filed 3–10–17; 8:45 am]
[FR Doc. 2017–04875 Filed 3–10–17; 8:45 am]
BILLING CODE 7020–02–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Federal Bureau of Investigation
Drug Enforcement Administration
[OMB Number 1110–0058]
[Docket No. DEA–392]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension
With Change, of a Currently Approved
Collection; National Incident-Based
Reporting System (NIBRS)
Bulk Manufacturer of Controlled
Substances Application: Siemens
Healthcare Diagnostics, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before May 12, 2017.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
December 14, 2016, Siemens Healthcare
Diagnostics, Inc., Attn: RA, 100 GBC
Drive, Mailstop 514, Newark, Delaware
19702 applied to be registered as a bulk
manufacturer of Ecgonine (9180) a basic
class of controlled substance listed in
schedule II.
The company plans to produce the
listed controlled substance in bulk to be
used in the manufacture of DEA exempt
products.
mstockstill on DSK3G9T082PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:49 Mar 10, 2017
Jkt 241001
Federal Bureau of
Investigation, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Federal Bureau of Investigation
(FBI), Criminal Justice Information
Services Division (CJIS), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until May
12, 2017.
FOR FURTHER INFORMATION CONTACT: All
comments, suggestions, or questions
regarding additional information, to
include obtaining a copy of the
proposed information collection
instrument with instructions, should be
directed to Mrs. Amy C. Blasher, Unit
Chief, Federal Bureau of Investigation,
Criminal Information Services Division,
Module E–3, 1000 Custer Hollow Road,
Clarksburg, West Virginia 26306;
facsimile (304) 625–3566.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Federal Bureau of
Investigation, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
SUMMARY:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension, with change of a currently
approved collection.
2. The Title of the Form/Collection:
National Incident-Based Reporting
System.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
The form number is 1110–0058. The
applicable component within the
Department of Justice is the Criminal
Justice Information Services Division, in
the Federal Bureau of Investigation.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: City, county, state, tribal and
federal law enforcement agencies.
Abstract: Under U.S. Code, Title 28,
Section 534, Acquisition, Preservation,
and Exchange of Identification Records;
Appointment of Officials, June 11, 1930;
Public Law 109–177 (H.R. 3199), March
9, 2006, USA Patriot Improvement and
Reauthorization Act of 2005; Public Law
110–457, Title II, Section 237(a), (b),
December 23, 2008, the William
Wilberforce Trafficking Victims
Reauthorization Act of 2008, and
Matthew Shepard Hate Crimes
Prevention Act, April 28, 2009, this
collection requests Incident data from
city, county, state, tribal and federal law
enforcement agencies in order for the
FBI UCR Program to serve as the
national clearinghouse for the collection
and dissemination of incident data and
to publish these statistics in Crime in
the United States, Hate Crime Statistics,
and Law Enforcement Officers Killed
and Assaulted. NIBRS is an incidentbased reporting system in which law
enforcement collects data on each crime
occurrence. Designed to be generated as
a byproduct of local, state, and federal
automated records systems, currently,
the NIBRS collects data on each
incident and arrest within 24 crime
categories made up of 52 specific crimes
called Group A offenses. For each of the
offenses coming to the attention of law
enforcement, various facts about the
crime are collected. In addition to the
Group A offenses, there are 10 Group B
offense categories for which only arrest
data are reported. The most significant
E:\FR\FM\13MRN1.SGM
13MRN1
]]>Agencies
[Federal Register Volume 82, Number 47 (Monday, March 13, 2017)]
[Notices]
[Page 13506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04875]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Siemens
Healthcare Diagnostics, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before May 12, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
December 14, 2016, Siemens Healthcare Diagnostics, Inc., Attn: RA, 100
GBC Drive, Mailstop 514, Newark, Delaware 19702 applied to be
registered as a bulk manufacturer of Ecgonine (9180) a basic class of
controlled substance listed in schedule II.
The company plans to produce the listed controlled substance in
bulk to be used in the manufacture of DEA exempt products.
Dated: March 6, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-04875 Filed 3-10-17; 8:45 am]
BILLING CODE 4410-09-P
